Minimizing time in culture: A prototypic autologous manufacturing workflow for monoclonal iPSC lines within seven weeks
A standardizable, automatable and time- efficient process for the derivation of monoclonal iPSC lines straight from skin including a comprehensive and cascaded ǪC strategy is developed, moving the field of autologous iPSC manufacturing one step further towards cost-efficient clinical implementation.